Moderna, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| M1RN34.SA | 6547.TWO | 0MGB.IL | 261780.KQ | 0A3M.IL | VIR | |
|---|---|---|---|---|---|---|
| Market cap | 568.03B | 15.63B | 296.30B | 103.62B | 25.17B | 1.99B |
| P/E (TTM) | — | — | 52.3 | — | 5.1 | — |
| Forward P/E | — | 32.6 | — | — | 5.1 | -4.8 |
| Price/book | 8.4 | 4.4 | 8.4 | — | 1.1 | 2.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +881.31% | +42.31% | +93.74% | +44.97% | −13.17% | +129.88% |
| Today | +12.92% | −2.16% | +2.14% | −2.90% | +2.81% | +4.90% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All M1RN34.SA news ›Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial
Moderna surges on pre-earnings momentum, Pfizer dips after beating estimates and raising guidance, and Merck drops despite launching a new trial. When stock prices and headlines point in opposite directions across the sector, something…
Could Investing in Moderna's Stock Double Your Money?
Intismeran is a promising cancer vaccine that has been highly effective when paired with Keytruda. Moderna is working with Merck on evaluating the vaccine for various types of cancers. Although the healthcare stock is up big this year,…
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
BioSpace Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (NASDAQ: PSNL) announced today
If Moderna's CEO Is Right, the Stock's Rally Could Just Be Getting Started
Stéphane Bancel has high hopes for the company's cancer vaccine, beyond just treating melanoma. Moderna (MRNA +0.13%) has been the hottest stock in the S&P 500 this year, and it hasn't been close. Up around 650%, the next-best-performing…
Stock Split Watch: Is Moderna Next?
The biotech quickly took charge of the situation, cutting costs where needed and putting a focus on oncology and rare disease candidates. All of these efforts have started to brighten Moderna's earnings reports, and investors have sat up…
Moderna, Inc. $MRNA Stock Sold by Bank Julius Baer & Co. Ltd Zurich
MRNA stock opened at $220.83 on Tuesday. The stock has a 50-day moving average price of $184.00 and a two-hundred day moving average price of $87.42. The company has a current ratio of 2.29, a quick ratio of 2.18 and a debt-to-equity ratio…
Bronstein, Gewirtz & Grossman, LLC Is Investigating Moderna, Inc. (MRNA) And Encourages Stockholders to Connect
The National Law Review Bronstein, Gewirtz & Grossman, LLC Is Investigating Moderna, Inc. (MRNA) And Encourages Stockholders to Connect On October 22, 2026, an early release of closely wa
Analyzing Insmed (NASDAQ:INSM) and Moderna (NASDAQ:MRNA)
Posted by Michael Walen on Nov 2nd, 2026 Moderna (NASDAQ:MRNA – Get Free Report) and Insmed (NASDAQ:INSM – Get Free Report) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses…
Buy Moderna Stock Before Q3 Earnings? Here's What to Know
Moderna MRNA is scheduled to report third-quarter 2026 earnings on Nov. 6, before the opening bell. The Zacks Consensus Estimate for sales is pinned at $888.8 million, while that for earnings is pegged at a loss of $1.37 per share. Both…
Moderna Stock Up 650% This Year as Personalized Cancer Vaccine Battle With Keytruda Patent Cliff Takes Shape
Moderna has gained roughly 650% in 2026, making it the S&P 500's top performer, driven by enthusiasm for intismeran, a personalized mRNA cancer vaccine developed with Merck. In a Phase 3 melanoma trial, the therapy combined with Keytruda…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- 247wallst.com22
- marketscreener.com22
- seekingalpha.com20
- theglobeandmail.com17
- fool.com15
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.